Table 3

- Multivariate analysis for the factors that are potentially associated with diabetic retinopathy by risk group.

 Low-risk(HbA1c ≤7)High-risk(HbA1c ≥9)
aORLowerCIUpperCIP-valueaORLowerCIUpper CIP-value
Age1.0120.9901.0360.2840.9700.9111.0330.338
BMI1.0140.9681.0610.5661.0210.9171.1370.701
Gender0.6110.3591.0400.0691.1230.3044.1510.862
SBP1.0080.9921.0240.3400.9960.9591.0340.825
DBP0.9880.9641.0130.3401.0280.9671.0940.375
HbA1c (last 12 months)0.7120.3831.3210.2811.0960.6451.8630.733
LDL1.0070.7121.4230.9701.1450.5642.3280.708
Albumin to creatinine ratio0.9930.9721.0140.4851.2250.7811.9230.377
Diabetes duration1.0250.9891.0620.1730.9980.9151.0900.972
ACEI/ARB use0.8190.4161.6090.5621.5240.3057.6260.608
Annual eGFR0.9970.9851.0090.5930.9920.9651.0200.555
  • Abbreviations, as in Table 2; aOR: adjusted odds ratio, CI: confidence interval, LDL: low-density lipoprotein, DBP: diastolic blood pressure, HbA1c: hemoglobin A1c, ACEI: angiotensin converting enzyme inhibitors, ARBs: angiotensin-receptor blockers, BMI: body mass index, SBP: systolic blood pressure,